AMERICAN JOURNAL OF CARDIOLOGY, 86(9), 1013–14. Use of fractional myocardial flow reserve to assess the functional significance of intermediate coronary stenoses. Use of fractional myocardial flow reserve to assess the functional significance of intermediate coronary stenosesįearon, W.Adequacy of intracoronary versus intravenous adenosine-induced maximal coronary hyperemia for fractional flow reserve measurements. Adequacy of intracoronary versus intravenous adenosine-induced maximal coronary hyperemia for fractional flow reserve measurements.Spatial orientation of atherosclerotic plaque in non-branching coronary artery segments. Spatial orientation of atherosclerotic plaque in non-branching coronary artery segments.Arterial remodeling - Mechanisms and clinical implications. Arterial remodeling - Mechanisms and clinical implications.Coronary artery compliance and adaptive vessel remodelling in patients with stable and unstable coronary artery disease. Coronary artery compliance and adaptive vessel remodelling in patients with stable and unstable coronary artery disease.Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study. Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) studyįitzgerald, P.Determinants of coronary remodeling in transplant coronary disease - A simultaneous intravascular ultrasound and Doppler flow study. R., Schwarzkopf, A., Giannetti, N., Hunt, S., … Yeung, A. Determinants of coronary remodeling in transplant coronary disease - A simultaneous intravascular ultrasound and Doppler flow study.Effects of intravenous and intracoronary adenosine 5 '-triphosphate as compared with adenosine on coronary flow and pressure dynamics. Effects of intravenous and intracoronary adenosine 5 '-triphosphate as compared with adenosine on coronary flow and pressure dynamics.Clinical applications of brachytherapy for the prevention of restenosis. Clinical applications of brachytherapy for the prevention of restenosis.His inventions focus on novel solutions in medication delivery to treat arterial sclerosis and vascular injury. Yeung holds patents for innovations in cardiac care. He has made invited presentations to his peers worldwide at meetings of the American College of Cardiology, Joint Interventional Meeting, Cardiac Intervention Today, and others.ĭr. He is a fellow of the American College of Cardiology. He has served as chairman of the board of the Internal Medicine Interventional Board Committee. Yeung plays an integral role in training the interventional cardiologists of the future. He was an editor-in-chief of the book Interventional Cardiology and has contributed chapters to many textbooks.ĭr. He is a reviewer for the Journal of Heart and Lung Transplantation, Journal of Vascular Medicine and Biology, Circulation, New England Journal of Medicine, and Lancet. He is on the editorial board of the Journal of the American College of Cardiology. Yeung has published his research findings in more than 300 articles in peer-reviewed journals such as the American Heart Journal, International Journal of Cardiology, and Circulation: Cardiovascular Intervention. He has received grants supporting his research from industry leaders as well as from the National Institutes of Health.ĭr. He has researched the placement of aortic transcatheter valves, use of a novel device to improve ventricular compliance, use of a vascular scaffold to treat coronary artery lesions, and other advances in techniques and technology. He has conducted numerous research studies as a principal investigator or co-investigator. He performs treatment procedures including transcatheter aortic valve replacement (TAVR), cardiac catheterization, and balloon valvuloplasty. Yeung provides care for the complete range of cardiovascular conditions such as coronary artery disease and heart valve disease. He is the past chief of the Stanford Medicine Division of Cardiovascular Medicine.ĭr. He is the Stanford University School of Medicine Li Ka Shing Professor in Cardiology. He completed fellowship training in cardiology. He has board certification in interventional cardiology, cardiovascular disease, and internal medicine. Yeung is a highly experienced, world-renowned interventional cardiologist and cardiologist.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |